Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001420596 | SCV001622913 | uncertain significance | Nicolaides-Baraitser syndrome | 2020-05-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004038182 | SCV004953851 | uncertain significance | Inborn genetic diseases | 2023-12-18 | criteria provided, single submitter | clinical testing | The c.880G>A (p.A294T) alteration is located in exon 5 (coding exon 4) of the SMARCA2 gene. This alteration results from a G to A substitution at nucleotide position 880, causing the alanine (A) at amino acid position 294 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |